Dr. Tremblay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-6756
Education & Training
- Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 2014 - 2017
- Albert Einstein College of MedicineClass of 2014
Certifications & Licensure
- NY State Medical License 2015 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- 7 citationsSplanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs.Angela Liu, Leonard Naymagon, Douglas Tremblay
Cancers. 2022-12-20 - 62 citationsRisk factors and outcomes of COVID-19 in New York City; a retrospective cohort study.Maaike van Gerwen, Mathilda Alsen, Christine Little, Joshua Barlow, Eric M. Genden
Journal of Medical Virology. 2021-02-01 - 48 citationsCancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.Andrew Schmidt, Ziad Bakouny, Sheena Bhalla, John A. Steinharter, Douglas Tremblay
Cancer Cell. 2020-12-14
Abstracts/Posters
- Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML PatientsDouglas Tremblay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center DatabaseDouglas Tremblay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein ThrombosisDouglas Tremblay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- FDA Approves Momelotinib (Ojjaara) for Myelofibrosis Patients with AnemiaSeptember 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: